Investment Rating - The industry investment rating is "Positive" and maintained [8] Core Insights - On January 28, the National Medical Products Administration approved two medical device industry standard revision projects related to brain-computer interface technology, which is expected to accelerate the commercialization of the brain-computer interface industry [5][12] - The rapid approval of these standards reflects the urgent need for establishing industry standards in the brain-computer interface sector, which is currently transitioning from technological research to clinical application and industrialization [12] - The brain-computer interface industry is experiencing significant technological breakthroughs, with a total of 2,041 related patents in China as of early 2026, of which over 90% are invention patents [12] Summary by Sections Event Description - The National Medical Products Administration has initiated two standard revision projects to support the high-quality development of medical devices utilizing brain-computer interface technology [5][12] Event Commentary - The approval of these standards is expected to provide a critical push for the development of brain-computer interfaces, facilitating their transition from laboratory research to clinical applications [12] - The industry is currently at a pivotal stage, with a growing number of patents and a need for standardized regulations to support its growth [12] - The government has recognized brain-computer interfaces as a key future industry, aiming to enhance their commercialization and integration into the healthcare system [12]
2项医疗器械行业标准制修订项目立项,脑机接口再迎政策利好
Changjiang Securities·2026-01-31 11:05